These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Dynamics of the gut microbiome, IgA response, and plasma metabolome in the development of pediatric celiac disease. Girdhar K; Dogru YD; Huang Q; Yang Y; Tolstikov V; Raisingani A; Chrudinova M; Oh J; Kelley K; Ludvigsson JF; Kiebish MA; Palm NW; Ludvigsson J; Altindis E Microbiome; 2023 Jan; 11(1):9. PubMed ID: 36639805 [TBL] [Abstract][Full Text] [Related]
45. Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten. Duar RM; Clark KJ; Patil PB; Hernández C; Brüning S; Burkey TE; Madayiputhiya N; Taylor SL; Walter J J Appl Microbiol; 2015 Feb; 118(2):515-27. PubMed ID: 25376327 [TBL] [Abstract][Full Text] [Related]
47. Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation. Lamas B; Hernandez-Galan L; Galipeau HJ; Constante M; Clarizio A; Jury J; Breyner NM; Caminero A; Rueda G; Hayes CL; McCarville JL; Bermudez Brito M; Planchais J; Rolhion N; Murray JA; Langella P; Loonen LMP; Wells JM; Bercik P; Sokol H; Verdu EF Sci Transl Med; 2020 Oct; 12(566):. PubMed ID: 33087499 [TBL] [Abstract][Full Text] [Related]
48. Healthy and pro-inflammatory gut ecology plays a crucial role in the digestion and tolerance of a novel Gluten Friendly™ bread in celiac subjects: a randomized, double blind, placebo control Andriulli A; Bevilacqua A; Palmieri O; Latiano A; Fontana R; Gioffreda D; Castellana S; Mazza T; Panza A; Menzaghi C; Grandone E; di Mauro L; Decina I; Tricarico M; Musaico D; Mäki M; Isola J; Popp A; Taavela J; Petruzzi L; Sinigaglia M; Rosaria Corbo M; Lamacchia C Food Funct; 2022 Feb; 13(3):1299-1315. PubMed ID: 35029612 [TBL] [Abstract][Full Text] [Related]
49. Children With Celiac Disease Consume Specific Food Additives More Frequently Compared to Children Without Celiac Disease. McDonnell E; Lampe JW; Nuding M; Lee D Dig Dis Sci; 2023 May; 68(5):1944-1949. PubMed ID: 36585541 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic accuracy of anti-gliadin antibodies in Non Celiac Gluten Sensitivity (NCGS) patients: A dual statistical approach. Infantino M; Manfredi M; Meacci F; Grossi V; Severino M; Benucci M; Bellio E; Bellio V; Nucci A; Zolfanelli F; Ugolini S; Catani S; Macchia D Clin Chim Acta; 2015 Dec; 451(Pt B):135-41. PubMed ID: 26404177 [TBL] [Abstract][Full Text] [Related]
51. Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy. Mohammed AD; Khan MAW; Chatzistamou I; Chamseddine D; Williams-Kang K; Perry M; Enos R; Murphy A; Gomez G; Aladhami A; Oskeritzian CA; Jolly A; Chang Y; He S; Pan Z; Kubinak JL Front Immunol; 2019; 10():2484. PubMed ID: 31708923 [TBL] [Abstract][Full Text] [Related]
53. Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice. Rune I; Rolin B; Larsen C; Nielsen DS; Kanter JE; Bornfeldt KE; Lykkesfeldt J; Buschard K; Kirk RK; Christoffersen B; Fels JJ; Josefsen K; Kihl P; Hansen AK PLoS One; 2016; 11(1):e0146439. PubMed ID: 26799618 [TBL] [Abstract][Full Text] [Related]
54. Immunological aspects of diagnosis of celiac sprue in children. Pozler O; Parízek J; Chýlková V; Nozicka Z; Fixa B; Bĕlobrádková I; Kubíková K Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1989; 32(2):169-233. PubMed ID: 2604776 [TBL] [Abstract][Full Text] [Related]
55. Clinical application of immunological markers as monitoring tests in celiac disease. Fotoulaki M; Nousia-Arvanitakis S; Augoustidou-Savvopoulou P; Kanakoudi-Tsakalides F; Zaramboukas T; Vlachonikolis J Dig Dis Sci; 1999 Oct; 44(10):2133-8. PubMed ID: 10548368 [TBL] [Abstract][Full Text] [Related]
56. The Gut-Renal Connection in IgA Nephropathy. Coppo R Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022 [TBL] [Abstract][Full Text] [Related]
57. Serological tests in gluten sensitivity (nonceliac gluten intolerance). Volta U; Tovoli F; Cicola R; Parisi C; Fabbri A; Piscaglia M; Fiorini E; Caio G J Clin Gastroenterol; 2012 Sep; 46(8):680-5. PubMed ID: 22138844 [TBL] [Abstract][Full Text] [Related]
58. Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review. Coto L; Mendia I; Sousa C; Bai JC; Cebolla A World J Gastroenterol; 2021 Oct; 27(37):6306-6321. PubMed ID: 34712034 [TBL] [Abstract][Full Text] [Related]
59. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease. Francavilla R; Cristofori F; Vacca M; Barone M; De Angelis M Expert Rev Gastroenterol Hepatol; 2020 May; 14(5):323-333. PubMed ID: 32216476 [TBL] [Abstract][Full Text] [Related]
60. Gut microbiota-CRAMP axis shapes intestinal barrier function and immune responses in dietary gluten-induced enteropathy. Ren Z; Pan LL; Huang Y; Chen H; Liu Y; Liu H; Tu X; Liu Y; Li B; Dong X; Pan X; Li H; Fu YV; Agerberth B; Diana J; Sun J EMBO Mol Med; 2021 Aug; 13(8):e14059. PubMed ID: 34125490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]